Lotus Eye Hospital and Institute share news, announcements and annual reports
NSE: LOTUSEYEBSE: 532998Healthcare ServicesSmall Cap
Lotus Eye Hospital and Institute Limited · Formerly Lotus Eye Care Hospital · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 2008
Last close ₹109.54down ₹0.11 (0.10%)BSE ₹109.85
Share price at the NSE close on 28 Oct 2026. Previous close ₹109.65.
28 Oct: open ₹110.00, high ₹111.79, low ₹109.10
52-week range of traded prices to 28 Oct 2026
₹97.59Low, 30 Mar 2026₹147.00High, 30 Jan 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹228 Cr2,287th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 1,525.81
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.79
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,40973.9% delivered
Lotus Eye Hospital and Institute disputes and clarifications
61 filed, newest first. Page 1 of 2.
Mar 2026
4 Mar · Legal
Nov 2025
29 Nov · Legal
Oct 2025
Sep 2025
8 Sep · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Jul 2025
1 Jul · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Mar 2025
11 Mar · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted -2. Consolidated Financial Results not submitted The response of the Company is awaited.
Dec 2024
7 Dec · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 30-Sep-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Sep 2024
3 Sep · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 30-Jun-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Jul 2024
Jun 2024
20 Jun · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Mar-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Apr 2024
Mar 2024
14 Mar · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Dec-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Jan 2024
Dec 2023
14 Dec · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 30-Sep-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Jun 2023
12 Jun · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted -2. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is awaited.
May 2023
11 May · Legal
The exchange asked on 10 May 2023
Mar 2023
Feb 2023
22 Feb · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Dec-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Dec 2022
15 Dec · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited with respect to Financial Results dated 14-Nov-2022 for the period Sep, 2022On the basis of aforesaid disclosure, the Listed entity is required to clarify the following:. Standalone: Segment Reporting : Not GivenThe response of the company is awaited
Aug 2022
30 Aug · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited with respect to Financial Results dated 09-Aug-2022 for the period Jun, 2022On the basis of aforesaid disclosure, the Listed entity is required to clarify the following:1. Standalone: Segment ReportingThe response of the company is awaited
Jun 2022
15 Jun · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
May 2022
11 May · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 30-Sep-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Mar 2022
17 Mar · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Dec-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Feb 2022
1 Feb · Legal
Significant movement in price has been observed in Lotus Eye Hospital and Institute Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Sep 2021
6 Sep · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 30-Jun-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Jul 2021
14 Jul · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted -2. Financial results not signed by authorized signatory/ies The response of the Company is awaited.
Feb 2021
17 Feb · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Dec-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Sep 2020
14 Sep · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 30-Jun-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Aug 2020
14 Aug · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited with respect to announcement dated 30-Jul-2020, regarding resignation of Mr. G R Karthikeyan as Independent Director of the Company. On basis of above the Company is required to clarify following: 1. Confirmation from resigning director that no other material reasons other than provided2. Detailed Reasons for ResignationThe response of the Company is awaited.3 Aug · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Mar-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. No Segment Reporting. -2. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.
Jun 2020
22 Jun · Legal
The exchange asked on 18 Jun 2020
Feb 2020
10 Feb · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Dec-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. No Segment Reporting. The response of the Company is awaited.
Jan 2020
16 Jan · Legal
Exchange has sought clarification from Lotus Eye Hospital and Institute Limited with respect to announcement dated 13-Jan-2020, regarding Board meeting held on January 13, 2020.On basis of above the Company is required to clarify following: 1. Brief profile and Date of appointment & term of appointment in case of appointment of Dr. S. Rajkumar. The response of the Company is awaited.
Nov 2019